chr2-189057366-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP3BP4_StrongBP6BS1BS2

The NM_000393.5(COL5A2):​c.2291C>G​(p.Pro764Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000402 in 1,608,322 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P764L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00070 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00037 ( 1 hom. )

Consequence

COL5A2
NM_000393.5 missense

Scores

12
4
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:9

Conservation

PhyloP100: 10.0

Publications

6 publications found
Variant links:
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
COL5A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, classic type, 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 10: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Cadd, Eigen, phyloP100way_vertebrate, PrimateAI, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.02394256).
BP6
Variant 2-189057366-G-C is Benign according to our data. Variant chr2-189057366-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 213106.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000697 (103/147864) while in subpopulation AMR AF = 0.00292 (43/14726). AF 95% confidence interval is 0.00223. There are 0 homozygotes in GnomAd4. There are 55 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 103 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000393.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL5A2
NM_000393.5
MANE Select
c.2291C>Gp.Pro764Arg
missense
Exon 34 of 54NP_000384.2P05997

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL5A2
ENST00000374866.9
TSL:1 MANE Select
c.2291C>Gp.Pro764Arg
missense
Exon 34 of 54ENSP00000364000.3P05997
COL5A2
ENST00000858728.1
c.2288C>Gp.Pro763Arg
missense
Exon 34 of 54ENSP00000528787.1
COL5A2
ENST00000858729.1
c.2291C>Gp.Pro764Arg
missense
Exon 34 of 53ENSP00000528788.1

Frequencies

GnomAD3 genomes
AF:
0.000697
AC:
103
AN:
147824
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000124
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00292
Gnomad ASJ
AF:
0.0119
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000164
Gnomad OTH
AF:
0.00147
GnomAD2 exomes
AF:
0.000776
AC:
195
AN:
251302
AF XY:
0.000817
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.0128
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000202
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000372
AC:
543
AN:
1460458
Hom.:
1
Cov.:
33
AF XY:
0.000366
AC XY:
266
AN XY:
726532
show subpopulations
African (AFR)
AF:
0.0000897
AC:
3
AN:
33456
American (AMR)
AF:
0.000962
AC:
43
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.0120
AC:
312
AN:
26076
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39630
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86242
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53256
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000963
AC:
107
AN:
1111028
Other (OTH)
AF:
0.00129
AC:
78
AN:
60320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000697
AC:
103
AN:
147864
Hom.:
0
Cov.:
31
AF XY:
0.000767
AC XY:
55
AN XY:
71672
show subpopulations
African (AFR)
AF:
0.000124
AC:
5
AN:
40318
American (AMR)
AF:
0.00292
AC:
43
AN:
14726
Ashkenazi Jewish (ASJ)
AF:
0.0119
AC:
41
AN:
3432
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4940
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4590
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
272
European-Non Finnish (NFE)
AF:
0.000164
AC:
11
AN:
67234
Other (OTH)
AF:
0.00146
AC:
3
AN:
2054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00101
Hom.:
0
Bravo
AF:
0.000778
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000552
AC:
67
EpiCase
AF:
0.000382
EpiControl
AF:
0.000296

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Ehlers-Danlos syndrome, classic type, 2 (2)
-
-
2
not provided (2)
-
-
1
COL5A2-related disorder (1)
-
1
-
Connective tissue disorder (1)
-
1
-
Ehlers-Danlos syndrome (1)
-
-
1
Ehlers-Danlos syndrome type 7A (1)
-
-
1
Ehlers-Danlos syndrome, classic type, 1 (1)
-
-
1
Familial thoracic aortic aneurysm and aortic dissection (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Pathogenic
0.51
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.83
D
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.75
T
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.024
T
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Uncertain
2.2
M
PhyloP100
10
PrimateAI
Pathogenic
0.83
D
PROVEAN
Pathogenic
-7.9
D
REVEL
Pathogenic
0.70
Sift
Uncertain
0.011
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.86
MVP
0.93
MPC
0.27
ClinPred
0.15
T
GERP RS
5.9
Varity_R
0.36
gMVP
0.63
Mutation Taster
=19/81
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150260969; hg19: chr2-189922092; COSMIC: COSV66410496; API